Psychedelics in psychiatry
Danilo Arnone, Fabrizio Schifano
The British Journal of Psychiatry December 30, 2005 DOI: 10.1192/bjp.188.1.88 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Citations | 2 |
| Key points | Argues that cognitive impairment in eating disorders may mask or distort personality subtypes, and recommends assessing personality during adequate nutrition. |
Abstract
It is likely therefore that cognitive impair-It is likely therefore that cognitive impairment was present in many.Hence the ment was present in many.Hence the 'personality subtypes' identified may vanish 'personality subtypes' identified may vanish on refeeding, or may be more pronounced, on refeeding, or may be more pronounced, having been masked by cognitive blunting.having been masked by cognitive blunting.It seems best to seek for personality sub-It seems best to seek for personality subtypes in eating disorders during periods of types in eating disorders during periods of adequate nutrition.adequate nutrition.
Citations in the library
Cites 6
- Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat Journal of Neuroscience July 1, 1998
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals Neuropsychobiology 2000
- RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy") Science September 27, 2002
- Can psychedelics have a role in psychiatry once again? The British Journal of Psychiatry June 1, 2005
- Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users Neuroreport October 1, 2003
and 1 more in the library